diagnostics ivd diagnostic in vitro diagnostics in-vitro diagnostic biomarkers biomarker product development analytical modeling market research market assessment forecasting product pipelines marketing strategy product management heart failure focus group rituxan product portfolio cardiovascular disorders chf drug portfolio drug pipeline troponin bnp acute coronary syndrome new product development marketing analysis epistemology companion diagnostics personalized medicine stroke rheumatoid arthritis business development medical devices strategic marketing r&d strategy dna sequencing next gen sequencing biotechnology and pharmaceuticals ngs dna bioinformatics genomics hiv hepatitis novartis roche hcv hologic gates foundation blood donation obamacare disease management (health) disease management ccp autoimmune lupus enbrel diagnostic algorithms discovery validation blood bank tropical diseases aabb china india aids chagas blood screening hmo medical imaging hospice hospitals biologicals pharmaceuticals health insurance portability and accountability ac accountable care organization aco dental physician offices cro labs hcit life science tools patient payor kellogg nanoarray microarray c. difficile myocardial infarction cardiotoxicity prostate cancer psa connective tissue disease allergen allergy nanotechnology licensing surveys strategic planning product screening divest spin off spin out cvc corporate venture capital quantitative research public health blood nucleic acid test point of care gen-probe gardasil affordable care act aca hecon health economics pharmacoeconomics patient protection and affordable care act
Mehr anzeigen